
Heather King, the founder of Addos Consulting, has over 20 years experience in the industry, including senior positions in pharmaceutical and biotechnology companies, as well as contract research organisations. With experience in medical writing, clinical research and project management in a number of pharmaceutical companies and CROs, Heather then completed an MBA and moved into the commercial side of the industry.
In Heather's clinical development career she rose to lead the clinical operations group in Syntex (now Roche) and spent much of her time working internationally, reporting into their Palo Alto HQ in California. Her commercial career has included Director level roles in Vernalis, Scotia Pharmaceuticals and Quintiles.
Addos Consulting has a network of associates who can provide the appropriate resources and expertise required for individual projects so that each project can be tailored appropriately.
Production of widely sold commercially available reports on deal making for the pharmaceutical industry
A detailed review of strategic options to support expansion in the EU market for a multinational company, including an assessment of competitor strategies, identification of M&A targets and an analysis of outsourcing options
Assessment of the market potential for a new product for a UK biotech company
Identification of acquisition targets for a multinational pharmaceutical company
Identification of licensing partners for a key product for an international pharmaceutical company
Identification of potential M&A targets for an AIM listed biotech company
Strategic and commercial support to establish a start-up biotech company
Corporate and business development support for an international CRO
Production of a commercially available report on pharmaceutical and biotechnology partnering, including interviews with senior industry personnel
Assessment of the commercial potential of a portfolio of products being considered for in-licensing by a large UK biotech company
Production of corporate presentations, press releases and media articles to support fundraising activities for a UK listed biotech company